1Rocchi E, Khodjakov A, Volk EL, et al. The product of the ABC halftransporter gene ABCG2 (BCRP/MXR/ABCP) is expressed in the plasma membrane. Biochem Biophys Res Commun, 2000, 271 : 42-46.
2Komatani H, Kotani H, Hara Y, et al. Identification of breast cancer resistant protein/mitoxantrone resistance/placenta-specific, ATP-binding cassette transporter as a transporter of NB-506 and J-107088,topoisomerase I inhibitors with an indolocarbazle structure. Cancer Res,2001, 61 : 2827-2832.
3Robey RW, Honjo Y, van de Laar A, et al. A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2).Biochim Biophys Acta,2001,1512: 171-182.
4Hendricks CB, Rowinsky EK, Grochow LB, et al. Effect of P-glycoprotein expression on the accumulation and cytotoxicity of topotecan (SK&F 104864), a new camptothecin analogue. Cancer Res,1992,52: 2268-2278.
5Doyle LA, Yang W, Abruzzo LV, et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA, 1998, 95: 15665-15670.
6Lage H, Dietel M. Effect of the breast-cancer resistance protein on atypical muhidrug resistance. Lancet Oncol, 2000, 1: 169-175.
7Maliepaard M, Scheffer GL, Faneyte IF, et al. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res, 2001, 61 : 3458-3464.
8Scheffer GL, Maliepaard M, Hjnenborg AC, et al. Breast cancer resistance protein is localized at the plasma membrane in mitoxantroneand topotecan-resistant cell lines. Cancer Res, 2000, 60: 2589-2593.
